Opiant Pharmaceuticals, Inc.

OPNT · NASDAQ
Analyze with AI
9/30/2022
6/30/2022
3/31/2022
12/31/2021
Operating Activities
Net Income-$10-$12-$12$1
Dep. & Amort.$0$0$0$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$2$0
Change in WC$4-$1$8$0
Other Non-Cash$0$0$0-$0
Operating Cash Flow-$5-$11-$2$2
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$12,515$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$2-$12,502$0
Investing Cash Flow-$0$2$13$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$2,571$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$1
Financing Cash Flow$0$0$0$1
Forex Effect-$0-$0-$0-$0
Net Chg. in Cash-$5-$8$10$3
Supplemental Information
Beg. Cash$40$48$38$35
End Cash$35$40$48$38
Free Cash Flow-$5-$11-$2$2
Opiant Pharmaceuticals, Inc. (OPNT) Financial Statements & Key Stats | AlphaPilot